Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                

Diabetes - FDA-Approved Diabetes Medicines

Download as pdf or txt
Download as pdf or txt
You are on page 1of 3

4/24/2018 Diabetes > FDA-Approved Diabetes Medicines

FDA-Approved Diabetes Medicines


All FDA-approved medicines used in the treatment of diabetes are either taken orally, injected, or inhaled, and can
be found at Drugs@FDA (http://www.accessdata.fda.gov/scripts/cder/daf/) or DailyMed
(http://dailymed.nlm.nih.gov/dailymed/about.cfm).

Diabetes Medicine Approved Between 2013 to Present

Brand Name Generic Name Approval Date

Steglujan ertugliflozin and sitagliptin December 20, 2017

Steglatro ertugliflozin December 19, 2017

Ozempic semaglutide December 5, 2017

Qtern dapagliflozin propanediol and saxagliptin hydrochloride February 27, 2017

Soliqua insulin glargine, lixisenatide November 2016

Xultophy insulin degludec, liraglutide November 2016

Basaglar insulin glargine injection December 2015

Tresiba insulin degludec injection September 2015

Ryzodeg insulin aspart: insulin degludec September 2015

Toujeo insulin glargine injection February 2015

Lucentis ranibizumab February 2015

Glyxambi empagliflozin and linagliptin January 2015

Synjardy empagliflozin/metformin January 2015

Trulicity dulaglutide September 2014

Invokamet canagliflozin and metformin hydrochloride August 2014

Jardiance empagliflozin August 2014

Afrezza Inhalation Powder insulin human June 2014

Tanzeum abliglutide May 2014

https://www.fda.gov/ForPatients/Illness/Diabetes/ucm408682.htm 1/3
4/24/2018 Diabetes > FDA-Approved Diabetes Medicines

Farxiga dapaglifozin January 2014

Invokana canagliflozin March 2013

Nesina alogliptin benzoate January 2013

Duetact pioglitazone hydrochloride and glimepiride January 2013

Diabetes Medicine Approved Between 2000-2012

Lucentis ranibizumab August 2012

Janumet XR sita linagliptin plus metformin hydrochloride February 2012

Jentadueto gliptin and metformin HCl extended-release February 2012

Bydureon exenatide synthetic January 2012

Juvisync sitagliptin and simvastatin October 2011

Kombiglyze XR saxagliptin/metformin hydrochloride extended-release November 2010

Victoza liraglutide January 2010

Onglyza saxagliptin July 2009

PrandiMet repaglinide/metformin hydrochloride June 2008

Janumet sitagliptin/metformin HCl March 2007

Januvia sitagliptin phosphate October 2006

ACTOplus met pioglitazone hydrochloride and metformin hydrochloride August 2005

Levemir insulin detemir June 2005

Byetta exenatide April 2005

Symlin pramlintide March 2005

Apidra insulin glulisine February 2004

Metaglip glipizide/metformin HCl October 2002

Avandamet rosiglitazone maleate and metformin HCl October 2002

Lantus insulin glargine April 2000

Novolog Insulin aspart November 2001

https://www.fda.gov/ForPatients/Illness/Diabetes/ucm408682.htm 2/3
4/24/2018 Diabetes > FDA-Approved Diabetes Medicines

Novolog 70/30 70% insulin aspart protamine and 30% insulin aspart November 2001

Diabetes Medicines Approved Before 1999

Humalog 75/25 75% insulin lispro protamine and 25% insulin lispro December 1999

Humalog insulin lispro June 1996

Humalog 50/50 50% insulin lispro protamine and 50% insulin lispro June 1996

Novolin 70/30 70% NPH and 30% regular June 1991

Novolin R regular (R) June 1991

Novolin N NPH (N) July 1991

Humulin 70/30 70% NPH and 30% regular April 1989

Humulin N NPH (N) October 1982

Humulin R 100U regular (R) Insulin October 1982

Humulin R 500U regular (R) Insulin (5 times concentration) October 1982

More in Diabetes
(/ForPatients/Illness/Diabetes/default.htm)

Diabetes Prevention (/ForPatients/Illness/Diabetes/ucm408100.htm)

Diabetes Treatment (/ForPatients/Illness/Diabetes/ucm408101.htm)

https://www.fda.gov/ForPatients/Illness/Diabetes/ucm408682.htm 3/3

You might also like